Demonstration of dose-response relationship in seasonal prophylaxis of respiratory infections with alpha-2b interferon.

Recombinant alpha-2b interferon was evaluated in two controlled trials, each lasting for 2 months or more, with different dose levels and schedules of administration. The first study was conducted during a period of transmission of type A (H1N1) and type B influenza. At 2.5 x 10(6) IU per day, no ef...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Monto, A S, Albrecht, J K, Schwartz, S A
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172096/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2831814/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.1.47
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!